Home › Funds › MONTANOVA CAPITAL, LLC › WHWK
MONTANOVA CAPITAL, LLC position in WHWK
WHITEHAWK THERAPEUTICS INC · Health Care
MONTANOVA CAPITAL, LLC reported holding 4,300,000 shares of WHWK (WHITEHAWK THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$19.7M, representing 0.36% of its reported portfolio and ranking #49 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed WHWK holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MONTANOVA CAPITAL, LLC's WHWK position evolved
MONTANOVA CAPITAL, LLC first disclosed a stake in WHWK in Q1 2025 at 3,700,000 shares (US$6.6M). The position peaked in Q2 2026 at 4,300,000 shares, worth US$19.7M. Across 6 filings, MONTANOVA CAPITAL, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 4,300,000 shares valued at US$19.7M — an increase of 600,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.70M | $6.59M | New |
| Q2 2025 | 3.70M | $6.92M | Hold |
| Q3 2025 | 3.70M | $7.03M | Hold |
| Q4 2025 | 3.70M | $8.95M | Hold |
| Q1 2026 | 3.70M | $12.77M | Hold |
| Q2 2026 | 4.30M | $19.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WHWK and 13F data
WHWK (WHITEHAWK THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in WHWK — the largest reported positions include Yu Fan (US$22.3M), ACUTA CAPITAL PARTNERS, LLC (US$21.5M), QVT Financial LP (US$21.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WHWK
- Yu Fan 4.86M sh · $22.26M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 4.69M sh · $21.46M · Q2 2026
- QVT Financial LP 4.62M sh · $21.14M · Q2 2026
- Avoro Capital Advisors LLC 2.85M sh · $13.05M · Q2 2026
- KVP Capital Advisors, LP 2.17M sh · $9.92M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.14M sh · $5.22M · Q2 2026
- STEMPOINT CAPITAL LP 1.02M sh · $4.68M · Q2 2026
- Ally Bridge Group (NY) LLC 817.94K sh · $3.75M · Q2 2026
- Verdad Advisers, LP 301.48K sh · $1.38M · Q2 2026
More on MONTANOVA CAPITAL, LLC
FAQ
How long has MONTANOVA CAPITAL, LLC held WHWK?
MONTANOVA CAPITAL, LLC has disclosed WHWK holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is MONTANOVA CAPITAL, LLC's current position in WHWK?
As of Q2 2026, MONTANOVA CAPITAL, LLC holds 4.30M shares of WHWK (WHITEHAWK THERAPEUTICS INC), valued at $19.69M, representing 0.36% of its reported portfolio and ranking #49.
Has MONTANOVA CAPITAL, LLC been buying or selling WHWK?
In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC increased its position in WHWK. The position peaked in Q2 2026 at 4.30M shares.
Which other funds hold WHWK?
Other major institutional holders of WHWK include Yu Fan, ACUTA CAPITAL PARTNERS, LLC, QVT Financial LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.